THE 2017 EUROPEAN LEUKEMIANET CLASSIFICATION PROVIDES ACCURATE PROGNOSIS IN AML.
The revised 2017 European LeukemiaNet (ELN) classification (ELN-2017) of acute myeloid leukemia (AML) divides patients into 3 prognostic risk categories, with additional factors such as the fms-like tyrosine kinase 3 (FLT3)-internal tandem duplication (ITD) allele ratio (AR) considered for risk stratification. To the best of the authors’ knowledge, the prognostic usefulness of ELN-2017 in comparison […]
THE 2017 EUROPEAN LEUKEMIANET CLASSIFICATION PROVIDES ACCURATE PROGNOSIS IN AML. Read More »
